1. Soleymani F, Valadkhani M, Dinarvand R. Challenges and 
achievements of promoting rational use of drug in Iran. Iran 
J Public Health 2009;38 Suppl 1:166‑8.
2. Ahmadizar F, Soleymani F, Abdollahi M. Study of drug‑drug 
interactions in prescriptions of general practitioners and 
specialists in Iran 2007‑2009. Iran J Pharm Res 2011;10:921‑31.
3. Soleymani F, Shalviri G, Abdollahi M. Pattern of use and 
adverse drug reactions of tramadol: A review of 336,610,664 
insured prescriptions during 5 years. Int J Pharmacol 
2011;7:757‑60.
4. Council on Credentialing in Pharmacy, Albanese NP, 
Rouse MJ. Scope of contemporary pharmacy practice: Roles, 
responsibilities, and functions of pharmacists and pharmacy 
technicians. J Am Pharm Assoc 2010;50:e35‑69.
5. Hanafi S, Poormalek F, Torkamandi H, Hajimiri M, Esmaeili M, 
Khooie SH, et al. Evaluation of community pharmacists’ 
knowledge, attitude and practice towards good pharmacy 
practice in Iran. J Pharm Care 2013;1:19‑24.
6. Soleymani F, Rashidian A, Dinarvand R, Kebriaeezade A, 
Hosseini M, Abdollahi M. Assessing the effectiveness and 
cost‑effectiveness of audit and feedback on physician’s 
prescribing indicators: Study protocol of a randomized 
controlled trial with economic evaluation. Daru 2012;20:88.
7. Hogerzeil HV. Promoting rational prescribing: An international 
perspective. Br J Clin Pharmacol 1995;39:1‑6.
8. Abdollahiasl A, Kebriaeezadeh A, Nikfar S, Farshchi A, 
Ghiasi G, Abdollahi M. Patterns of antibiotic consumption in 
Iran during 2000‑2009. Int J Antimicrob Agents 2011;37:489‑90.
9. Cheraghali AM, Soleymani F, Behmanesh Y, Rahimi V, 
Hbibipour F, Tirdad R, et al. Physicians’ attitude toward 
injectable medicines. J Pharmacol Toxicol 2006;1:33‑9.
10. Soleymani F, Abdollahi M. Management information 
system in promoting rational drug use. Int J Pharmacol 
2012;8:586‑9.
11. Farshchi M, Jaberidoost M, Abdollahiasl A, Abdollahi M. 
Efficacies of regulatory policies to control massive use of 
diphenoxylate. Int J Pharmacol 2012;8:459‑62.
12. Nikfar S, Khatibi M, Abdollahi‑Asl M, Abdollahi M. Cost 
and utilization study of antidotes: An Iranian experience. Int 
J Pharmacol 2011;7:46‑9.
13. Cordina M, McElnay JC, Hughes CM. The importance that 
community pharmacists in Malta place on the introduction 
of pharmaceutical care. Pharm World Sci 1999;21:69‑73.
14. Rawlins MD. Extending the role of the community pharmacist. 
BMJ 1991;302:427‑8.
15. Hepler CD, Strand LM. Opportunities and responsibilities in 
pharmaceutical care. Am J Hosp Pharm 1990;47:533‑43.
16. Benjamin H, Smith F, Motawi MA. Drugs dispensed with 
and without a prescription from community pharmacies 
in a conurbation in Egypt. East Meditter Health J 
1996;1:506‑14.
17. Traulsen JM, Almarsdóttir AB. Pharmaceutical policy and the 
pharmacy profession. Pharm World Sci 2005;27:359‑63.
18. Laing RO, Ruredzo R. The essential drugs program in 
Zimbabwe: New approaches to training. Health Policy Plan 
1989;4:229‑34.
19. GarjaniA, Salimnejad M, Shamsmohamadi M, Baghchevan V, 
Vahidi RG, Maleki‑Dijazi N, et al. Effect of interactive group 
discussion among physicians to promote rational prescribing. 
East Mediterr Health J 2009;15:408‑15.
20. Freemantle N, Harvey EL, Wolf F, Grimshaw JM, Grilli R, 
Bero LA. Printed educational materials: Effects on professional 
practice and health care outcomes. Cochrane Database Syst Rev 1997;2:CD000172.
21. Gray J. Changing physician prescribing behaviour. Can J Clin 
Pharmacol 2006;13:e81‑4.
22. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, 
Bero L, et al. Changing provider behavior: An overview of 
systematic reviews of interventions. Med Care 2001;39:II2‑45.